DASH Trial

Start date:
June 2019

Why?

Medications to ‘thin’ the blood can have an unwanted effect on strokes caused by bleeding in the brain. Controlling bleeding is crucial in the first few hours after stroke but there is still uncertainty over the best course of treatment.

What?

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

https://clinicaltrials.gov/ct2/show/NCT03696121